US5317090A
(en)
*
|
1987-12-16 |
1994-05-31 |
Institut Pasteur |
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor
|
CA1320161C
(en)
*
|
1987-12-16 |
1993-07-13 |
Hugues Blaudin De The |
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor
|
US5217867A
(en)
*
|
1988-11-30 |
1993-06-08 |
The Salk Institute For Biological Studies |
Receptors: their identification, characterization, preparation and use
|
EP0451206A4
(en)
*
|
1988-12-23 |
1992-07-22 |
The Salk Institute For Biological Studies |
Receptor transcription-repression activity compositions and methods
|
WO1990014356A1
(en)
*
|
1989-05-26 |
1990-11-29 |
The Salk Institute For Biological Studies |
Dominant negative members of the steroid/thyroid superfamily of receptors
|
ATE166360T1
(de)
*
|
1989-03-17 |
1998-06-15 |
Salk Inst For Biological Studi |
Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon
|
US5260432A
(en)
*
|
1989-06-22 |
1993-11-09 |
Sloan-Kettering Institute For Cancer Research |
Human gamma retinoic acid receptor DNA
|
US5665543A
(en)
*
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
US5776502A
(en)
*
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
JPH05504254A
(ja)
*
|
1989-10-25 |
1993-07-08 |
ザ ソーク インスティテュート フォア バイオロジカル スタディーズ |
レセプター感染アッセイ
|
AU637446B2
(en)
*
|
1990-01-16 |
1993-05-27 |
Baylor College Of Medicine |
Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors
|
ATE196310T1
(de)
|
1990-02-09 |
2000-09-15 |
Salk Inst For Biological Studi |
Retinoid-rezeptor-zusammensetzungen und verfahren
|
US5688691A
(en)
*
|
1990-03-22 |
1997-11-18 |
The Salk Institute For Biological Studies |
Insect retinoid-like receptor compositions and methods
|
US5861274A
(en)
*
|
1990-03-22 |
1999-01-19 |
The Salk Institute For Biological Studies |
Nucleic acids encoding peroxisome proliferator-activated receptor
|
AU655417B2
(en)
*
|
1990-03-22 |
1994-12-22 |
Salk Institute For Biological Studies, The |
Insect retinoid receptor compositions and methods
|
US6440681B1
(en)
|
1990-04-03 |
2002-08-27 |
Merck & Co., Inc. |
Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
|
US5369028A
(en)
*
|
1990-04-03 |
1994-11-29 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
|
US5599906A
(en)
*
|
1990-04-13 |
1997-02-04 |
Schering Corporation |
Protease assays
|
IL97996A0
(en)
*
|
1990-04-30 |
1992-06-21 |
Novo Nordisk As |
Hybrid cellular receptor
|
DK106490D0
(da)
*
|
1990-04-30 |
1990-04-30 |
Novo Nordisk As |
Celle
|
US5401629A
(en)
*
|
1990-08-07 |
1995-03-28 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Assay methods and compositions useful for measuring the transduction of an intracellular signal
|
KR930703462A
(ko)
*
|
1990-09-24 |
1993-11-30 |
로저 브렌트 |
검색 분석 방법
|
US5922596A
(en)
*
|
1990-12-10 |
1999-07-13 |
Bristol-Myers Squibb Co. |
Promoter of the retinoic acid receptor gene for directing gene expression
|
JPH06505152A
(ja)
*
|
1990-12-21 |
1994-06-16 |
ザ ロックフェラー ユニヴァーシティ |
肝集積性転写因子
|
EP0575528A4
(en)
*
|
1991-03-18 |
1994-09-14 |
Salk Inst For Biological Studi |
Response element compositions and assays employing same
|
US5834213A
(en)
*
|
1991-05-02 |
1998-11-10 |
Baylor College Of Medicine |
Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
|
WO1992022667A1
(en)
*
|
1991-06-14 |
1992-12-23 |
University Of Medicine And Dentistry Of New Jersey |
Analogs of glycoprotein hormone receptors which bind choriogonadotrophins, leutrophins, and follitrophins and methods for preparing and using same
|
AU2516092A
(en)
*
|
1991-08-23 |
1993-03-16 |
Ligand Pharmaceuticals, Inc. |
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
|
US5871909A
(en)
*
|
1991-08-30 |
1999-02-16 |
The Regents Of The University Of Michigan |
Human cellular retinoic acid binding protein I and II DNA and methods of use
|
AU2579692A
(en)
*
|
1991-09-17 |
1993-04-27 |
Salk Institute For Biological Studies, The |
Receptor of the thyroid/steroid hormone receptor superfamily
|
DE4138621A1
(de)
*
|
1991-11-25 |
1993-06-17 |
Boehringer Ingelheim Int |
Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
|
WO1993012141A1
(en)
*
|
1991-12-11 |
1993-06-24 |
Yale University |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
US6004924A
(en)
|
1991-12-11 |
1999-12-21 |
Imperial Cancer Research Technology, Ltd. |
Protein sequences of serrate gene products
|
US5869282A
(en)
*
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
US7056954B2
(en)
*
|
1991-12-18 |
2006-06-06 |
The Salk Institute For Biological Studies |
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
|
US6506917B1
(en)
*
|
1991-12-18 |
2003-01-14 |
The Salk Institute For Biological Studies |
Compounds and compositions useful for modulation of processes mediated by RXR
|
US5968989A
(en)
|
1991-12-18 |
1999-10-19 |
The Salk Institute For Biological Studies |
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
|
EP0552612A3
(en)
*
|
1992-01-22 |
1993-10-20 |
Hoffmann La Roche |
Methods for determining and isolating compounds which bind directly to nucleosolic proteins
|
US5756448A
(en)
*
|
1992-02-26 |
1998-05-26 |
The General Hospital Corporation |
Constitute activator of retinoid (CAR) receptor polypeptides
|
US6989242B1
(en)
|
1992-02-26 |
2006-01-24 |
The General Hospital Coporation |
Car receptors and related molecules and methods
|
EP0637296A4
(de)
*
|
1992-04-21 |
1996-02-07 |
Ligand Pharm Inc |
Nicht-steroide verbindungen mit agonistischer und antagonistischer aktivität am progesteronrezeptor und verfahren zu ihrer verwendung.
|
US5808139A
(en)
*
|
1992-04-21 |
1998-09-15 |
Ligand Pharmaceuticals Incorporated |
Non-steroid progesterone receptor agonist and antagonist and compounds and methods
|
US5780676A
(en)
*
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
US5962731A
(en)
*
|
1992-04-22 |
1999-10-05 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
JPH08500963A
(ja)
*
|
1992-04-28 |
1996-02-06 |
ザ・リージェンツ・オブ・ザ・ユニヴァーシティー・オブ・ミシガン |
ヒューマンcrabp−▲i▼及びcrabp−▲ii▼
|
US6416998B1
(en)
*
|
1992-09-02 |
2002-07-09 |
Baylor College Of Medicine |
Plasmid encoding a modified steroid hormone
|
ATE365209T1
(de)
*
|
1992-05-14 |
2007-07-15 |
Baylor College Medicine |
Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
|
WO1994008049A1
(en)
*
|
1992-10-01 |
1994-04-14 |
The General Hospital Corporation |
Functional assay for tumor suppressor genes
|
AU5165193A
(en)
*
|
1992-10-07 |
1994-04-26 |
Merck & Co., Inc. |
Human steroid hormone receptor neri
|
DK0680517T4
(da)
*
|
1993-01-21 |
2005-05-02 |
Harvard College |
Fremgangsmåde og diagnostiske sæt til bestemmelse af en forbindelses toksicitet under anvendelse afstress-promotorer fra pattedyr
|
HUT73101A
(en)
*
|
1993-02-12 |
1996-06-28 |
Harvard College |
Method for regulating transcription of targeted genes and other biological events
|
US6891021B2
(en)
|
1993-02-12 |
2005-05-10 |
Board Of Trustees Of The Leland Stanford Junior University |
Regulated apoptosis
|
WO1994020617A2
(en)
|
1993-03-08 |
1994-09-15 |
The Salk Institute Biotechnology/Industrial Associates, Incorporated |
Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
|
SG54115A1
(en)
*
|
1993-04-27 |
1998-11-16 |
Gerber Scient Products Inc |
Thermal printing apparatus with improved power supply
|
US6031149A
(en)
|
1993-05-18 |
2000-02-29 |
Institut National De La Sante Et De La Recherche Medicale |
Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
|
CA2140354A1
(en)
*
|
1993-05-18 |
1994-11-24 |
Pierre Chambon |
Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
|
US5677336A
(en)
*
|
1993-10-21 |
1997-10-14 |
Ligand Pharmaceuticals Incorporated |
Non-steroid androgen receptor antagonist compounds and methods
|
US5506102A
(en)
*
|
1993-10-28 |
1996-04-09 |
Ligand Pharmaceuticals Incorporated |
Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription
|
AU1091595A
(en)
*
|
1993-11-08 |
1995-05-29 |
Salk Institute Biotechnology/Industrial Associates, Inc., The |
Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
|
US5523209A
(en)
*
|
1994-03-14 |
1996-06-04 |
The Scripps Research Institute |
Methods for identifying inhibitors of integrin activation
|
AU2109695A
(en)
|
1994-03-30 |
1995-10-23 |
Novartis Ag |
Screening method using the rzr receptor family
|
EP0769052A2
(de)
*
|
1994-07-01 |
1997-04-23 |
The Salk Institute For Biological Studies |
Säugertier peroxisompoliferator-aktivierte rezeptoren und verwendungen davon
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US5607967A
(en)
*
|
1994-10-27 |
1997-03-04 |
Merck & Co., Inc. |
Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
|
US5679518A
(en)
*
|
1994-10-27 |
1997-10-21 |
Merck & Co., Inc. |
Method for finding transcription activators of the NER steroid hormone receptor
|
US5702914A
(en)
*
|
1994-12-21 |
1997-12-30 |
The Salk Institute For Biological Studies |
Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements
|
US5932699A
(en)
|
1995-01-13 |
1999-08-03 |
The General Hospital Corporation |
Retinoid X receptor-interacting polypeptides
|
AU711041B2
(en)
*
|
1995-01-17 |
1999-10-07 |
Salk Institute For Biological Studies, The |
Methods, polypeptides, nucleotide sequence of XOR-6, a vitamin D-like receptor from xenopus
|
FR2732035B1
(fr)
*
|
1995-03-23 |
1997-05-30 |
Agronomique Inst Nat Rech |
Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
|
AU4745996A
(en)
*
|
1995-04-28 |
1996-11-18 |
Wisconsin Alumni Research Foundation |
Method for measuring hormones in biological samples
|
US6485967B1
(en)
|
1995-06-07 |
2002-11-26 |
Merck & Co., Inc. |
Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
|
US5726050A
(en)
*
|
1995-06-20 |
1998-03-10 |
Massachusetts Institute Of Technology |
Z-DNA binding protein and applications
|
US5777888A
(en)
*
|
1995-08-09 |
1998-07-07 |
Regents Of The University Of California |
Systems for generating and analyzing stimulus-response output signal matrices
|
US6326140B1
(en)
*
|
1995-08-09 |
2001-12-04 |
Regents Of The University Of California |
Systems for generating and analyzing stimulus-response output signal matrices
|
US5569588A
(en)
*
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6489441B1
(en)
*
|
1995-09-01 |
2002-12-03 |
The Salk Institute For Biological Studies |
Transcriptional co-repressor that interacts with nuclear hormone receptors
|
AU715528B2
(en)
*
|
1995-09-08 |
2000-02-03 |
Karo Bio Ab |
Orphan receptor
|
CA2204616C
(en)
|
1995-09-18 |
2002-12-17 |
Ranjan Mukherjee |
Ppar gamma antagonists for treating obesity
|
PT873295E
(pt)
*
|
1995-10-06 |
2003-08-29 |
Ligand Pharm Inc |
Moduladores de rxr selectivos para dimeros para a sua utilizacao
|
EA003423B1
(ru)
|
1995-10-10 |
2003-04-24 |
Новартис Аг |
Штамм трансгенных растительных клеток и трансгенное растение, содержащие кассету экспрессии полипептида-мишени usp рецептора, способы получения их потомства, способы регулирования экспрессии полипептида-мишени в указанном растении с помощью ювенильного гормона или его агонистов, способы выявления и получения лиганда для полипептида usp рецептора и соответствующий лиганд
|
US20030044914A1
(en)
*
|
1996-01-16 |
2003-03-06 |
The Salk Institute For Biological Studies |
Methods employing XOR-6, a vitamin D-like receptor from xenopus
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
US5919667A
(en)
*
|
1996-06-20 |
1999-07-06 |
The Salk Institute For Biological Studies |
Modular assembly retroviral vectors and uses thereof
|
US6017924A
(en)
|
1996-06-27 |
2000-01-25 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
WO1998027986A1
(en)
*
|
1996-12-24 |
1998-07-02 |
Zymogenetics, Inc. |
Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
|
US6268165B1
(en)
|
1997-03-19 |
2001-07-31 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
US6184256B1
(en)
|
1997-04-24 |
2001-02-06 |
INSTITUT NATIONAL DE LA SANTé DE LA RECHERCHE MéDICALE |
Methods and compositions for use in modulating expression of matrix metalloproteinase genes
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
US6528271B1
(en)
*
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
US6300488B1
(en)
|
1997-07-10 |
2001-10-09 |
The Salk Institute For Biological Studies |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
|
US6222015B1
(en)
|
1997-09-08 |
2001-04-24 |
Merck & Co., Inc. |
Estrogen receptor
|
US6521814B1
(en)
|
1997-12-22 |
2003-02-18 |
Institut National De La Santa Et De La Recherche Medicale |
Use of ligands for treatment of diseases responsive to retinoids
|
US6348348B1
(en)
*
|
1998-04-07 |
2002-02-19 |
The Carnegie Institution Of Washington |
Human hairless gene and protein
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
AU4676999A
(en)
|
1998-06-12 |
1999-12-30 |
Ligand Pharmaceuticals, Inc. |
Treatment of anti-estrogen resistant breast cancer using rxr modulators
|
US6504082B1
(en)
|
1998-09-10 |
2003-01-07 |
Pioneer Hi-Bred International, Inc. |
Ecdysone receptors and methods for their use
|
EP1114153A2
(de)
*
|
1998-09-18 |
2001-07-11 |
The Rockefeller University |
Lynx, eine neue familie von rezeptorligande im zentralnervensystem, entsprechende nukleinsaüre und proteine und verwendungen davon
|
DE19855013C2
(de)
*
|
1998-11-20 |
2001-09-13 |
Schering Ag |
Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
|
US6773911B1
(en)
*
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
US7056656B1
(en)
|
1999-01-25 |
2006-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
|
US20020132223A1
(en)
*
|
1999-03-26 |
2002-09-19 |
City Of Hope |
Methods for modulating activity of the FXR nuclear receptor
|
US6548739B2
(en)
*
|
1999-06-18 |
2003-04-15 |
City Of Hope |
Method for activating peroxisome proliferator activated receptor-γ
|
US6586189B2
(en)
|
1999-06-18 |
2003-07-01 |
City Of Hope |
Screening method for PPAR-γ ligands
|
CA2378298A1
(en)
|
1999-08-27 |
2001-03-08 |
Lawrence G. Hamann |
8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
|
PL353792A1
(en)
|
1999-08-27 |
2003-12-01 |
Ligand Pharmaceuticals Incorporatedligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
US6566372B1
(en)
*
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
AU5701399A
(en)
*
|
1999-09-01 |
2001-03-26 |
Bristol-Myers Squibb Company |
In vitro transcription systems and uses
|
CA2383565A1
(en)
|
1999-09-14 |
2001-03-22 |
Ligand Pharmaceuticals Incorporated |
Rxr modulators with improved pharmacologic profile
|
WO2001021215A1
(en)
*
|
1999-09-22 |
2001-03-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Cell based assay
|
CA2386095A1
(en)
|
1999-09-30 |
2001-04-05 |
Hollis-Eden Pharmaceuticals, Inc. |
Therapeutic treatment of androgen receptor driven conditions
|
US7057015B1
(en)
*
|
1999-10-20 |
2006-06-06 |
The Salk Institute For Biological Studies |
Hormone receptor functional dimers and methods of their use
|
US7329728B1
(en)
|
1999-10-25 |
2008-02-12 |
The Scripps Research Institute |
Ligand activated transcriptional regulator proteins
|
JP4048053B2
(ja)
|
1999-11-26 |
2008-02-13 |
マクギル ユニバーシティー |
特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法
|
PT1741447E
(pt)
|
2000-01-21 |
2013-12-11 |
Novartis Ag |
Combinações que compreendem o inibidor da dipeptidilpeptidase-iv
|
AU2001241682A1
(en)
*
|
2000-02-24 |
2001-09-03 |
The Salk Institute For Biological Studies |
Gene expression system based on chimeric receptors
|
US20040033600A1
(en)
*
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
US20020022599A1
(en)
*
|
2000-03-24 |
2002-02-21 |
Synold Timothy W. |
Methods of modulating drug clearance mechanisms by altering SXR activity
|
AU2001271579A1
(en)
*
|
2000-06-28 |
2002-01-08 |
University Technology Corporation |
Progesterone receptor-regulated gene expression and methods related thereto
|
US7011972B2
(en)
|
2000-07-18 |
2006-03-14 |
The Scripps Research Institute |
Fusion polypeptide comprising two ligand binding domains
|
AU7254401A
(en)
*
|
2000-07-18 |
2002-01-30 |
Novartis Ag |
Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
AU2002251724B2
(en)
*
|
2000-10-24 |
2007-06-21 |
Syngenta Participations Ag |
Control of gene expression in plants
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US7018812B2
(en)
*
|
2000-11-03 |
2006-03-28 |
Duke University |
Modified G-protein coupled receptors
|
US20050136431A1
(en)
*
|
2000-11-03 |
2005-06-23 |
Oakley Robert H. |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US20040053839A1
(en)
*
|
2000-12-21 |
2004-03-18 |
Andrea Leblanc |
Method of protecting cells against apoptosis and assays to identify agents which modulate apoptosis
|
ES2385598T3
(es)
|
2001-02-20 |
2012-07-27 |
Intrexon Corporation |
Sistema novedoso de expresión génica inducible basado en el receptor de ecdisona/receptor X retinoide de invertebrado
|
EP3470520A2
(de)
|
2001-02-20 |
2019-04-17 |
Intrexon Corporation |
Neuartige substitution mutanter rezeptoren und deren verwendung in einem auf nuklearen rezeptoren beruhenden induzierbaren genexpressionssystem
|
WO2002066615A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
ES2424812T3
(es)
|
2001-02-20 |
2013-10-08 |
Intrexon Corporation |
Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
|
US7214690B2
(en)
*
|
2001-02-23 |
2007-05-08 |
Ligand Pharmaceuticals Incorporated |
Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
|
US20040102367A1
(en)
*
|
2001-02-23 |
2004-05-27 |
Gage Fred H |
Gene expression system based on chimeric receptors
|
US7026484B2
(en)
*
|
2001-02-23 |
2006-04-11 |
Ligand Pharmaceuticals Incorporated |
Tricyclic androgen receptor modulator compounds and methods
|
US20040143015A1
(en)
*
|
2001-03-12 |
2004-07-22 |
Villhauer Edwin Bernard |
Combination of organic compounds
|
WO2002072528A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Eli Lilly And Company |
Fluorinated trienes and their use as rxr modulators
|
US20030003517A1
(en)
*
|
2001-03-22 |
2003-01-02 |
Klein Elliott S. |
Methods of detecting dissociated nuclear hormone receptor ligands
|
US20050176928A1
(en)
*
|
2001-03-23 |
2005-08-11 |
Syngenta Participations Ag |
Insect nuclear receptor genes and uses thereof
|
US20040235169A1
(en)
*
|
2001-04-20 |
2004-11-25 |
Evans Ronald M. |
Inducible expression of transfected genes
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
EP2335728A1
(de)
|
2001-05-11 |
2011-06-22 |
Ludwig Institute for Cancer Research Ltd. |
Spezifische Bindeproteine und deren Verwendungen
|
WO2002095405A1
(en)
*
|
2001-05-21 |
2002-11-28 |
The Regents Of The University Of California |
Membrane-resident steroid receptors and methods of use thereof
|
US20040248913A1
(en)
*
|
2001-07-20 |
2004-12-09 |
Grese Timothy Alan |
(Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
|
WO2003012113A2
(en)
*
|
2001-08-02 |
2003-02-13 |
Gencell S.A. |
Inducible expression systems employing ppar transcriptional activators
|
EP1288303A1
(de)
*
|
2001-08-23 |
2003-03-05 |
Aventis Pharma S.A. |
Induzierbare Expressionssysteme unter Verwendung von PPAR Transkriptionsaktivatoren
|
EP1490686A2
(de)
*
|
2001-09-26 |
2004-12-29 |
RheoGene Holdings Inc. |
Weisse-fliege-ecdyson-rezeptor-nukleinsäuren, -polypeptide und ihre verwendungen
|
CA2459827C
(en)
*
|
2001-09-26 |
2013-09-03 |
Subba Reddy Palli |
Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
AU2002327787A1
(en)
*
|
2001-09-28 |
2003-04-07 |
Gordon L. Hager |
Glucocorticoid receptor nuclear translocation domain
|
US20030212138A1
(en)
*
|
2002-01-14 |
2003-11-13 |
Pharmacia Corporation |
Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
|
US20030220374A1
(en)
*
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
US7455988B2
(en)
*
|
2002-05-29 |
2008-11-25 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
US8673589B2
(en)
|
2002-05-29 |
2014-03-18 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
US7375093B2
(en)
|
2002-07-05 |
2008-05-20 |
Intrexon Corporation |
Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
EP1388352A1
(de)
|
2002-08-08 |
2004-02-11 |
Laboratoires Fournier S.A. |
Verwendung eines ppar-alpha-Agonisten zur Behandlung von Patienten, die an mit ppar-gamma-Agonisten-Behandlung assozierter Fettleibigkeit leiden
|
WO2004029246A2
(en)
|
2002-09-26 |
2004-04-08 |
K.U.Leuven Research And Development |
Integrase cofactor
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
US7304162B2
(en)
*
|
2003-02-21 |
2007-12-04 |
Intrexon Corporation |
Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
EP1641555B1
(de)
|
2003-04-30 |
2020-12-02 |
Nexus Biosystems, Inc. |
Hochdichte lagerung und eine analyseplattform bereitstellende mehrlochplatte
|
CA2536349A1
(en)
*
|
2003-08-22 |
2005-03-03 |
Ligand Pharmaceuticals Incorporated |
6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
|
US7767792B2
(en)
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
US7935510B2
(en)
*
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
WO2005115992A1
(en)
|
2004-05-23 |
2005-12-08 |
Housey Pharmaceuticals, Inc. |
Theramutein modulators
|
US20090214514A1
(en)
*
|
2004-07-23 |
2009-08-27 |
Leif Kongskov Larsen |
Gus3 neuropeptides for regulating hypothalamic function
|
US7544838B2
(en)
|
2005-01-21 |
2009-06-09 |
City Of Hope |
Ligands for estrogen related receptors and methods for synthesis of said ligands
|
US8431110B2
(en)
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
WO2006138347A2
(en)
*
|
2005-06-17 |
2006-12-28 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
HRP20140091T4
(hr)
|
2005-09-14 |
2021-12-24 |
Takeda Pharmaceutical Company Limited |
Davanje inhibitora dipeptidil peptidaze
|
CN103789389B
(zh)
*
|
2005-11-23 |
2017-01-04 |
杰勒德·M·豪斯 |
鉴定、合成、优化和表征蛋白调节剂的化合物和方法
|
US20080107597A1
(en)
*
|
2006-01-12 |
2008-05-08 |
Anaptys Biosciences, Inc. |
Isolation of antibodies that cross-react and neutralize rankl originating from multiple species
|
EP3357904B1
(de)
|
2007-05-29 |
2022-07-06 |
Precigen, Inc. |
Chirale diachylhydrazin-liganden zur modulation der expression exogener gene über einen ecdyson-rezeptorkomplex
|
AU2008289461A1
(en)
|
2007-08-23 |
2009-02-26 |
Intrexon Corporation |
Methods and compositions for diagnosing disease
|
US20090136465A1
(en)
|
2007-09-28 |
2009-05-28 |
Intrexon Corporation |
Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
|
ES2531522T3
(es)
|
2007-10-08 |
2015-03-16 |
Intrexon Corporation |
Células dendríticas modificadas por ingeniería y usos para el tratamiento del cáncer
|
MX2010006972A
(es)
|
2007-12-21 |
2010-08-26 |
Ligand Pharm Inc |
Moduladores selectivos de receptores de andrógenos (sarm) y usos de los mismos.
|
WO2009114201A2
(en)
|
2008-03-14 |
2009-09-17 |
Intrexon Corporation |
Steroidal ligands and their use in gene switch modulation
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
WO2011041293A1
(en)
|
2009-09-30 |
2011-04-07 |
Takeda Pharmaceutical Company Limited |
Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
|
JP5711270B2
(ja)
|
2010-02-03 |
2015-04-30 |
武田薬品工業株式会社 |
アポトーシスシグナル調節キナーゼ1阻害剤
|
EP3284821B1
(de)
|
2010-03-23 |
2022-01-05 |
Precigen, Inc. |
Vektoren zur bedingten expression therapeutischer proteine, wirtszellen mit diesen vektoren und verwendungen davon
|
EP3450568A3
(de)
|
2011-03-04 |
2019-04-24 |
Intrexon Corporation |
Vektoren für bedingte proteinexpression
|
KR20150129034A
(ko)
|
2013-03-15 |
2015-11-18 |
인트렉손 코포레이션 |
붕소-함유 디아실하이드라진류
|
EP3094323A4
(de)
|
2014-01-17 |
2017-10-11 |
Ligand Pharmaceuticals Incorporated |
Verfahren und zusammensetzungen zur modulierung von hormonspiegeln
|
CN107406373B
(zh)
|
2014-09-17 |
2020-04-28 |
英特瑞克斯顿股份有限公司 |
含硼的二酰基肼化合物
|
UY37343A
(es)
|
2016-07-25 |
2018-02-28 |
Intrexon Corp |
Control del fenotipo en plantas
|
NZ752941A
(en)
|
2016-11-09 |
2023-04-28 |
Intrexon Corp |
Frataxin expression constructs
|
WO2018195339A1
(en)
|
2017-04-19 |
2018-10-25 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|